Serial analysis of 3D H-1 MRSI for patients with newly diagnosed GBM treated with combination therapy that includes bevacizumab

Serial analysis of 3D H-1 MRSI for patients with newly diagnosed GBM treated with combination therapy that includes bevacizumab

Interpretation of changes in the T1- and T2-weighted MR images from patients with newly diagnosed glioblastoma (GBM) treated with standard of care in conjunction with anti-angiogenic agents is complicated by pseudoprogression and pseudoresponse. The hypothesis being tested in this study was that 3D...

Full description

Bibliographic Details
Main Authors: Nelson, Sarah J., Li, Yan, Lupo, Janine M., Olson, Marram, Crane, Jason C., Molinaro, Annette, Roy, Ritu, Clarke, Jennifer, Butowski, Nicholas, Prados, Michael, Cha, Soonmee, Chang, Susan M.
Format: Online
Language:English
Published: Springer US 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069332/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069332/

Similar Items